A Phase I Study Investigating the Safety and Efficacy of the MagSenseTM Human Epidermal Growth Factor Receptor 2 (HER2) Test Reagent Using Magnetic Resonance Imaging and the MagSenseTM Instrument in Subjects with HER2-positive Breast Cancer to Test for Ipsilateral Lymph Node Involvement

Project: Research

Project Details

Project Description

NMA HREC Reference Number: SVHM HREC ref 181/20
NMA SSA Reference Number: SSA/67965/MonH-2020-241202(v2)
Monash Health Reference: RES-20-0000-861X
Effective start/end date25/11/2024/11/25


  • breast cancer
  • magnetic resonance imaging
  • treatment efficacy
  • treatment safety
  • breast surgery